Harald Grut

858 total citations
19 papers, 522 citations indexed

About

Harald Grut is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Harald Grut has authored 19 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 11 papers in Surgery and 11 papers in Oncology. Recurrent topics in Harald Grut's work include Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers) and Colorectal Cancer Treatments and Studies (6 papers). Harald Grut is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers) and Colorectal Cancer Treatments and Studies (6 papers). Harald Grut collaborates with scholars based in Norway, United States and Sweden. Harald Grut's co-authors include Svein Dueland, Pål‐Dag Line, Trygve Syversveen, Morten Hagness, Steinar Solberg, Jon Magnus Solheim, Bjørn Atle Bjørnbeth, Stein Gunnar Larsen, T Egge and Therese Seierstad and has published in prestigious journals such as Annals of Surgery, British journal of surgery and American Journal of Transplantation.

In The Last Decade

Harald Grut

17 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harald Grut Norway 9 443 394 213 70 61 19 522
Jon Magnus Solheim Norway 4 229 0.5× 208 0.5× 113 0.5× 45 0.6× 41 0.7× 10 279
Hyeyoung Kim South Korea 13 516 1.2× 381 1.0× 92 0.4× 241 3.4× 44 0.7× 33 601
Eung Chang Lee South Korea 10 176 0.4× 235 0.6× 57 0.3× 64 0.9× 59 1.0× 21 295
Lakhbir Sandhu Canada 8 347 0.8× 263 0.7× 87 0.4× 173 2.5× 17 0.3× 11 444
Kaitlyn R. Musto United States 8 244 0.6× 265 0.7× 56 0.3× 99 1.4× 41 0.7× 13 337
Ivan Capobianco Germany 9 274 0.6× 270 0.7× 113 0.5× 101 1.4× 10 0.2× 31 402
K. Thrum Germany 12 306 0.7× 215 0.5× 57 0.3× 168 2.4× 37 0.6× 21 399
Ailton Sepulveda France 12 268 0.6× 302 0.8× 56 0.3× 67 1.0× 22 0.4× 30 371
Ernesto Castro Spain 10 144 0.3× 267 0.7× 196 0.9× 77 1.1× 28 0.5× 25 385
Abdallah Slim Italy 9 375 0.8× 273 0.7× 35 0.2× 148 2.1× 19 0.3× 11 413

Countries citing papers authored by Harald Grut

Since Specialization
Citations

This map shows the geographic impact of Harald Grut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Grut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Grut more than expected).

Fields of papers citing papers by Harald Grut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harald Grut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Grut. The network helps show where Harald Grut may publish in the future.

Co-authorship network of co-authors of Harald Grut

This figure shows the co-authorship network connecting the top 25 collaborators of Harald Grut. A scholar is included among the top collaborators of Harald Grut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald Grut. Harald Grut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kryeziu, Kushtrim, Ina A. Eilertsen, Luís Nunes, et al.. (2025). Molecular prognostic factors for liver transplantation of unresectable metastatic colorectal cancer. British journal of surgery. 112(4).
2.
Dueland, Svein, et al.. (2024). The prognostic value of [18F]FDG PET/CT texture analysis prior to transplantation for unresectable colorectal liver metastases. Clinical Physiology and Functional Imaging. 45(1). e12908–e12908.
3.
Dueland, Svein, et al.. (2023). Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal Cancer for Liver Transplant. JAMA Surgery. 158(9). e232932–e232932. 36 indexed citations
4.
Grut, Harald, Pål‐Dag Line, Trygve Syversveen, & Svein Dueland. (2023). Metabolic Tumor Volume from 18F-FDG PET/CT in Combination with Radiologic Measurements to Predict Long-Term Survival Following Transplantation for Colorectal Liver Metastases. Cancers. 16(1). 19–19. 3 indexed citations
5.
Grut, Harald, Pål‐Dag Line, Trygve Syversveen, & Svein Dueland. (2022). Metabolic tumor volume predicts long-term survival after transplantation for unresectable colorectal liver metastases: 15 years of experience from the SECA study. Annals of Nuclear Medicine. 36(12). 1073–1081. 12 indexed citations
7.
Grut, Harald, Pål‐Dag Line, Knut Jørgen Labori, Anselm Schulz, & Svein Dueland. (2021). Survival after liver resection and liver transplantation for colorectal liver metastases: a comparative analysis stratified by metabolic tumor volume assessed by 18F-FDG PET/CT. HPB. 24(7). 1055–1062. 7 indexed citations
8.
Dueland, Svein, Bård I. Røsok, Harald Grut, et al.. (2021). Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases. Transplant International. 34(11). 2205–2213. 15 indexed citations
9.
Dueland, Svein, Trygve Syversveen, Morten Hagness, Harald Grut, & Pål‐Dag Line. (2021). Liver transplantation for advanced liver-only colorectal metastases. British journal of surgery. 108(12). 1402–1405. 6 indexed citations
10.
Grut, Harald, Åslaug Helland, Simon Ekman, et al.. (2021). Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study. Duo Research Archive (University of Oslo). 4 indexed citations
12.
Grut, Harald, et al.. (2020). Preoperative 18F-FDG PET/computed tomography predicts survival following resection for colorectal liver metastases. Nuclear Medicine Communications. 41(9). 916–923. 7 indexed citations
13.
Dueland, Svein, Jon Magnus Solheim, Aksel Foss, et al.. (2020). Dismal survival following liver transplantation for liver-only metastases in patients with ocular malignant melanoma. 13(3). 2 indexed citations
14.
Dueland, Svein, Harald Grut, Trygve Syversveen, Morten Hagness, & Pål‐Dag Line. (2019). Selection criteria related to long-term survival following liver transplantation for colorectal liver metastasis. American Journal of Transplantation. 20(2). 530–537. 64 indexed citations
15.
Dueland, Svein, Trygve Syversveen, Jon Magnus Solheim, et al.. (2019). Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases. Annals of Surgery. 271(2). 212–218. 181 indexed citations
16.
Dueland, Svein, Harald Grut, Trygve Syversveen, Morten Hagness, & Pål‐Dag Line. (2019). Selection Criteria Related to Long Term Survival Following Liver Transplantation for Colorectal Liver Metastasis. SSRN Electronic Journal. 1 indexed citations
17.
Grut, Harald, Mona-Elisabeth Revheim, Pål‐Dag Line, & Svein Dueland. (2018). Importance of 18F-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation. Nuclear Medicine Communications. 39(7). 621–627. 23 indexed citations
18.
Grut, Harald, et al.. (2017). The prognostic value of 18F–FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases. European Journal of Nuclear Medicine and Molecular Imaging. 45(2). 218–225. 45 indexed citations
19.
Grut, Harald, Steinar Solberg, Therese Seierstad, et al.. (2017). Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases. British journal of surgery. 105(3). 295–301. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026